These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23613814)

  • 1. Identification of human monoclonal antibodies specific for human SOD1 recognizing distinct epitopes and forms of SOD1.
    Broering TJ; Wang H; Boatright NK; Wang Y; Baptista K; Shayan G; Garrity KA; Kayatekin C; Bosco DA; Matthews CR; Ambrosino DM; Xu Z; Babcock GJ
    PLoS One; 2013; 8(4):e61210. PubMed ID: 23613814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states.
    Prudencio M; Borchelt DR
    Mol Neurodegener; 2011 Nov; 6():77. PubMed ID: 22094223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS.
    Rakhit R; Robertson J; Vande Velde C; Horne P; Ruth DM; Griffin J; Cleveland DW; Cashman NR; Chakrabartty A
    Nat Med; 2007 Jun; 13(6):754-9. PubMed ID: 17486090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1.
    Zhao B; Marciniuk K; Gibbs E; Yousefi M; Napper S; Cashman NR
    Vaccine; 2019 Aug; 37(35):4920-4927. PubMed ID: 31324499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases.
    Ayers JI; Xu G; Pletnikova O; Troncoso JC; Hart PJ; Borchelt DR
    Acta Neuropathol Commun; 2014 May; 2():55. PubMed ID: 24887207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice.
    Xu G; Ayers JI; Roberts BL; Brown H; Fromholt S; Green C; Borchelt DR
    Hum Mol Genet; 2015 Feb; 24(4):1019-35. PubMed ID: 25305079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.
    Gros-Louis F; Soucy G; Larivière R; Julien JP
    J Neurochem; 2010 Jun; 113(5):1188-99. PubMed ID: 20345765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.
    Gertz B; Wong M; Martin LJ
    J Neuropathol Exp Neurol; 2012 Feb; 71(2):162-77. PubMed ID: 22249462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregate-selective antibody attenuates seeded aggregation but not spontaneously evolving disease in SOD1 ALS model mice.
    Lehmann M; Marklund M; Bolender AL; Bidhendi EE; Zetterström P; Andersen PM; Brännström T; Marklund SL; Gilthorpe JD; Nordström U
    Acta Neuropathol Commun; 2020 Sep; 8(1):161. PubMed ID: 32928301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis.
    Ekhtiari Bidhendi E; Bergh J; Zetterström P; Forsberg K; Pakkenberg B; Andersen PM; Marklund SL; Brännström T
    Acta Neuropathol; 2018 Dec; 136(6):939-953. PubMed ID: 30284034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.
    Kerman A; Liu HN; Croul S; Bilbao J; Rogaeva E; Zinman L; Robertson J; Chakrabartty A
    Acta Neuropathol; 2010 Mar; 119(3):335-44. PubMed ID: 20111867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.
    Prudencio M; Durazo A; Whitelegge JP; Borchelt DR
    J Neurochem; 2009 Feb; 108(4):1009-18. PubMed ID: 19077113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis.
    Liu HN; Tjostheim S; Dasilva K; Taylor D; Zhao B; Rakhit R; Brown M; Chakrabartty A; McLaurin J; Robertson J
    J Neurosci; 2012 Jun; 32(26):8791-9. PubMed ID: 22745481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox properties of the disulfide bond of human Cu,Zn superoxide dismutase and the effects of human glutaredoxin 1.
    Bouldin SD; Darch MA; Hart PJ; Outten CE
    Biochem J; 2012 Aug; 446(1):59-67. PubMed ID: 22651090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic immunoprecipitation approach reinforces the concept of common conformational alterations in amyotrophic lateral sclerosis-linked SOD1 mutants.
    Fujisawa T; Yamaguchi N; Kadowaki H; Tsukamoto Y; Tsuburaya N; Tsubota A; Takahashi H; Naguro I; Takahashi Y; Goto J; Tsuji S; Nishitoh H; Homma K; Ichijo H
    Neurobiol Dis; 2015 Oct; 82():478-486. PubMed ID: 26297318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice.
    Keskin I; Ekhtiari Bidhendi E; Marklund M; Andersen PM; Brännström T; Marklund SL; Nordström U
    Acta Neuropathol Commun; 2021 Jun; 9(1):111. PubMed ID: 34158126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.
    Jonsson PA; Graffmo KS; Andersen PM; Brännström T; Lindberg M; Oliveberg M; Marklund SL
    Brain; 2006 Feb; 129(Pt 2):451-64. PubMed ID: 16330499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1.
    Prudencio M; Durazo A; Whitelegge JP; Borchelt DR
    Hum Mol Genet; 2010 Dec; 19(24):4774-89. PubMed ID: 20871097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.